Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia.
Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia. EBioMedicine. 2015 Apr; 2(4):284.
View in:
PubMed
subject areas
Adrenergic beta-2 Receptor Agonists
Cholesterol, LDL
Dyslipidemias
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Molecular Targeted Therapy
authors with profiles
Michael H. Davidson